These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 34097300)
21. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Böhm M; Schumacher H; Teo KK; Lonn EM; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder RE; Sliwa K; Weber MA; Williams B; Yusuf S Lancet; 2017 Jun; 389(10085):2226-2237. PubMed ID: 28390695 [TBL] [Abstract][Full Text] [Related]
22. Single Agent Antihypertensive Therapy and Orthostatic Blood Pressure Behaviour in Older Adults Using Beat-to-Beat Measurements: The Irish Longitudinal Study on Ageing. Canney M; O'Connell MD; Murphy CM; O'Leary N; Little MA; O'Seaghdha CM; Kenny RA PLoS One; 2016; 11(1):e0146156. PubMed ID: 26730962 [TBL] [Abstract][Full Text] [Related]
23. Effect of Intensive Blood Pressure Lowering on Cardiovascular Outcomes: A Systematic Review Prepared for the 2020 U.S. Department of Veterans Affairs/U.S. Department of Defense Guidelines. D'Anci KE; Tipton K; Hedden-Gross A; Rouse B; Hermanson L; Fontanarosa J Ann Intern Med; 2020 Dec; 173(11):895-903. PubMed ID: 32866419 [TBL] [Abstract][Full Text] [Related]
24. Incremental effects of antihypertensive drugs: instrumental variable analysis. Markovitz AA; Mack JA; Nallamothu BK; Ayanian JZ; Ryan AM BMJ; 2017 Dec; 359():j5542. PubMed ID: 29273586 [TBL] [Abstract][Full Text] [Related]
25. [Comparison of initiation of antihypertensive therapy strategies for primary prevention of cardiovascular diseases in Chinese population: A decision-analytic Markov modelling study]. Zhou T; Liu Q; Zhang M; Liu X; Kang J; Shen P; Lin H; Tang X; Gao P Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Jun; 56(3):441-447. PubMed ID: 38864129 [TBL] [Abstract][Full Text] [Related]
26. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT). Sun X; Guo Y; Nie Z; Cheng J; Zhou H; Zhong X; Zhang S; Du Z; Zhuang X; Liao X Clin Res Cardiol; 2019 Mar; 108(3):273-281. PubMed ID: 30167807 [TBL] [Abstract][Full Text] [Related]
28. Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical Trial. Sheppard JP; Burt J; Lown M; Temple E; Lowe R; Fraser R; Allen J; Ford GA; Heneghan C; Hobbs FDR; Jowett S; Kodabuckus S; Little P; Mant J; Mollison J; Payne RA; Williams M; Yu LM; McManus RJ; JAMA; 2020 May; 323(20):2039-2051. PubMed ID: 32453368 [TBL] [Abstract][Full Text] [Related]
29. Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trials. Atkins ER; Hirakawa Y; Salam A; Woodward M; Cooper M; Hamet P; Harrap S; Lees K; Liu L; Mancia G; Marre M; Perkovic V; Poulter N; Williams B; Chalmers J; Rodgers A J Hypertens; 2017 Jun; 35(6):1318-1325. PubMed ID: 28169881 [TBL] [Abstract][Full Text] [Related]
30. Systolic blood pressure, antihypertensive treatment, and cardiovascular and mortality risk in VA nursing home residents. Liu X; Steinman MA; Lee SJ; Peralta CA; Graham LA; Li Y; Jing B; Fung KZ; Odden MC J Am Geriatr Soc; 2023 Jul; 71(7):2131-2140. PubMed ID: 36826917 [TBL] [Abstract][Full Text] [Related]
32. Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study. Li C; Chen K; Cornelius V; Tomeny E; Wang Y; Yang X; Yuan X; Qin R; Yu D; Wu Z; Wang D; Chen T PLoS Med; 2021 Mar; 18(3):e1003515. PubMed ID: 33661907 [TBL] [Abstract][Full Text] [Related]
33. Blood pressure targets in adults with hypertension. Arguedas JA; Leiva V; Wright JM Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004349. PubMed ID: 33332584 [TBL] [Abstract][Full Text] [Related]
34. Treatment of Hypertension: Which Goal for Which Patient? Jarraya F Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961 [TBL] [Abstract][Full Text] [Related]
35. The COMmon control of hypErtenSion and Therapeutic Attitudes in Belgium and Luxemburg study (COME STAI). van de Borne P; Missault L; Persu A; Van Mieghem W Acta Cardiol; 2016 Feb; 71(1):35-40. PubMed ID: 26853251 [TBL] [Abstract][Full Text] [Related]
36. Hypertension treatment practices and its determinants among ambulatory patients: retrospective cohort study in Ethiopia. Berhe DF; Taxis K; Haaijer-Ruskamp FM; Mulugeta A; Mengistu YT; Mol PGM BMJ Open; 2017 Aug; 7(8):e015743. PubMed ID: 28775184 [TBL] [Abstract][Full Text] [Related]
37. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial. Heisler M; Hofer TP; Schmittdiel JA; Selby JV; Klamerus ML; Bosworth HB; Bermann M; Kerr EA Circulation; 2012 Jun; 125(23):2863-72. PubMed ID: 22570370 [TBL] [Abstract][Full Text] [Related]
38. Effect of discontinuation of antihypertensive medication on orthostatic hypotension in older persons with mild cognitive impairment: the DANTE Study Leiden. Moonen JE; Foster-Dingley JC; de Ruijter W; van der Grond J; de Craen AJ; van der Mast RC Age Ageing; 2016 Mar; 45(2):249-55. PubMed ID: 26758532 [TBL] [Abstract][Full Text] [Related]
39. Treatment With Multiple Blood Pressure Medications, Achieved Blood Pressure, and Mortality in Older Nursing Home Residents: The PARTAGE Study. Benetos A; Labat C; Rossignol P; Fay R; Rolland Y; Valbusa F; Salvi P; Zamboni M; Manckoundia P; Hanon O; Gautier S JAMA Intern Med; 2015 Jun; 175(6):989-95. PubMed ID: 25685919 [TBL] [Abstract][Full Text] [Related]